Lilly - March 2026 - case study 1
Start date:
Optimising Intravenous (IV) Infusion, Magnetic Resonance Imaging (MRI), and Outpatient Pathways for Alzheimer’s Disease (AD) Treatment
Last reviewed date: 30 April 2026
Next review date: 30 April 2029